DIAGNOS (OTCMKTS:DGNOF) Shares Down 1.3% – Should You Sell?

DIAGNOS Inc. (OTCMKTS:DGNOF)’s share price dropped 1.3% on Wednesday . The company traded as low as $0.15 and last traded at $0.15. Approximately 28,000 shares traded hands during mid-day trading, a decline of 39% from the average daily volume of 46,090 shares. The stock had previously closed at $0.15.

DIAGNOS Price Performance

The business’s fifty day simple moving average is $0.17 and its 200-day simple moving average is $0.20. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.23. The firm has a market cap of $15.08 million, a P/E ratio of -3.70 and a beta of 0.25.

DIAGNOS (OTCMKTS:DGNOF) last announced its quarterly earnings results on Wednesday, May 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01). The firm had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.09 million.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.